Katarina Nägga
11 – 20 of 84
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
e-learning and web-based tools for psychosocial interventions addressing neuropsychiatric symptoms of dementia during the covid-19 pandemic in tokyo, japan : Quasi-experimental study
(
- Contribution to journal › Article
- 2020
-
Mark
Cerebrospinal fluid lipocalin 2 as a novel biomarker for the differential diagnosis of vascular dementia
(
- Contribution to journal › Article
-
Mark
Beta-blocker therapy and risk of vascular dementia : A population-based prospective study
(
- Contribution to journal › Article
-
Mark
Midlife Atherosclerosis and Development of Alzheimer or Vascular Dementia
(
- Contribution to journal › Article
-
Mark
High circulating levels of midregional proenkephalin A predict vascular dementia : a population-based prospective study
(
- Contribution to journal › Article
-
Mark
Alpha-amylase 1A copy number variants and the association with memory performance and Alzheimer’s dementia
(
- Contribution to journal › Article
-
Mark
Incretin hormones, insulin, glucagon and advanced glycation end products in relation to cognitive function in older people with and without diabetes, a population-based study
(
- Contribution to journal › Article
-
Mark
Cognitive test results are associated with mortality and rehospitalization in heart failure : Swedish prospective cohort study
(
- Contribution to journal › Article
- 2019
-
Mark
Antipsychotic Treatment Associated With Increased Mortality Risk in Patients With Dementia. A Registry-Based Observational Cohort Study
(
- Contribution to journal › Article
-
Mark
Levels of islet amyloid polypeptide in cerebrospinal fluid and plasma from patients with Alzheimer’s disease
(
- Contribution to journal › Article